BIOCYTOGEN PHARMA. H YC1 Free Cash Flow Generation Index
BIOCYTOGEN PHARMA. H YC1 free cash flow generation index. BIOCYTOGEN PHARMA. H YC1 (I54) has a Free Cash Flow Generation Index of 0.76x as of December 2025. Free cash flow of €282.43 Million represents 1% of operating cash flow (€370.25 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of BIOCYTOGEN PHARMA. H YC1 (2024–2025)
Free cash flow generation index of BIOCYTOGEN PHARMA. H YC1 from 2024 to 2025. Historical FCF Generation Index trend for BIOCYTOGEN PHARMA. H YC1 across 2 annual periods. See I54 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
BIOCYTOGEN PHARMA. H YC1 Free Cash Flow Generation Index by Year (2024–2025)
BIOCYTOGEN PHARMA. H YC1 free cash flow generation index by year from 2024 to 2025. Year-by-year Free Cash Flow Generation Index for BIOCYTOGEN PHARMA. H YC1. For the full cash flow conversion analysis, see how efficiently does BIOCYTOGEN PHARMA. H YC1 generate cash.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.76x | €282.43 Million | €370.25 Million | €87.82 Million | ▼ -7.5% |
| 2024 | 0.82x | €174.12 Million | €211.25 Million | €37.13 Million | — |